Our systems allow for the quantitative assessment of sensorimotor performance, neurologically based motor deficiencies, and brain function deficits.
By putting cutting-edge technology into the hands of neuroscientists and clinician-scientists around the world, we give our customers a "window" on brain function that is objective and quantitative – allowing them to study, with exquisite precision, the sensory, motor and cognitive impact of a wide range of brain injuries and diseases, such as stroke, cardiac arrest, transient ischemic attach, traumatic brain injury, multiple sclerosis and Parkinson's disease.
On the other hand, The PROTXX Machine Learning Engine exploits unique features in phybrata signals to derive digital biomarkers that classify impairments to different physiological systems based on their unique biomechanical vibrational signatures.
Items marked with* are investigational devices and for research use only. CAUTION - Investigational Device. Limited by Federal (or United States) law to investigational use.